← Open Payments lookup

LAURA DAVIS: Open Payments

NPI 1780691063 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$988 in 34 payments from 14 companies in 2025. Trend: 2023 $906 · 2024 $2,245 · 2025 $988

Food & beverage: $988
CompanyPaymentsAmount
ABBVIE INC.4$213
Merck Sharp & Dohme LLC5$133
AstraZeneca Pharmaceuticals LP5$127
Myriad Genetic Laboratories, Inc.2$99
GlaxoSmithKline, LLC.4$86
E.R. Squibb & Sons, L.L.C.3$81
Novartis Pharmaceuticals Corporation2$55
Astellas Pharma US Inc2$50
PFIZER INC.2$41
Daiichi Sankyo Inc.1$24

Products named: ELAHERE, KEYTRUDA, MYRISK, LYNPARZA, JEMPERLI, SCEMBLIX, IMFINZI, Veozah.

Industry payments across TX — which companies pay providers there.